On Tuesday, Shares of Rite Aid Corporation (NYSE:RAD), gained 2.83% to $9.08, hitting its highest level.
RediClinic declared donations totaling $40,000 to eight YMCAs serving the greater Baltimore/Washington D.C., Philadelphia and Seattle areas. RediClinic, which opened convenient care clinics inside select Rite Aid pharmacies in each market earlier this year, is making the donation as part of its continued commitment to the health and well-being of the communities they serve.
Each YMCA will use the donation to support various programs that will benefit the health and wellbeing of children in its communities throughout the year. RediClinic will present each of the eight YMCAs with a check for $5,000 during a series of special in-store events this week.
In the greater Baltimore area, RediClinic will donate $5,000 to YMCA of Central Maryland; in Philadelphia, Central Bucks Family YMCA, Community YMCA of Eastern Delaware County, Lower Bucks Family YMCA and Philadelphia Freedom Valley YMCA; in greater Seattle, YMCA of Greater Seattle and YMCA of Snohomish County; and in Washington D.C., YMCA of Metropolitan Washington.
RediClinic is a wholly owned partner of the Rite Aid Corporation.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Shares of Hologic Inc. (NASDAQ:HOLX), declined -0.43% to $41.39, during its last trading session.
Hologic declared that the Company will present at the Canaccord Genuity Growth Conference in Boston on Wednesday, August 12 at 3:30 p.m. Eastern Time (ET) and the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 16, 2015 at 11:40 a.m. ET.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
Finally, Cognex Corporation (NASDAQ:CGNX), ended its last trade with -22.14% loss, and closed at $35, hitting its lowest level.
Cognex Corporation declared its results for the second quarter of 2015. In Table 1 below, selected financial data for the quarter and six months ended July 5, 2015 is contrast to the first quarter of 2015, second quarter of 2014 and the first six months of 2014.
Sale of Cognex’s Surface Inspection Systems Division
Cognex sold its Surface Inspection Systems Division (SISD) on July 6, 2015 in order to focus all of its efforts on discrete manufacturing where the company sees stronger long-term growth opportunities. Revenue from SISD was $11.2 million in Q2 2015. If SISD’s results had not been stated as a suspended operation pending divestiture, our revenue for Q2 2015 would have been $155 million, as contrast to the guidance that was given on May 4, 2015 of $152 million to $157 million.
The “Details of the Quarter” DISCUSSED below excludes the financial results of SISD. For a historical perspective, Exhibit 4 comprises Cognex’s quarterly Statement of Operations for 2014 with the results of SISD stated as a suspended operation.
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes. It operates in two divisions, Modular Vision Systems and Surface Inspection Systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
